Regenerex Pharma (RGPX) Other Accumulated Expenses (2022 - 2023)
Regenerex Pharma (RGPX) reported Other Accumulated Expenses of $13171.0 for Q1 2023, little changed year-over-year from $13120.0 in Q1 2022, and little changed quarter-over-quarter from $13120.0 in Q1 2022.
Regenerex Pharma (RGPX) Other Accumulated Expenses (2022 - 2023) Analysis & Trends
Regenerex Pharma (RGPX) has 2 years of Other Accumulated Expenses data on file, last reported at $13171.0 in Q1 2023.
- Other Accumulated Expenses for Q1 2023 came in at $13171.0, changed 0.39% year-over-year; the trailing twelve-month figure through Mar 2023 was $13171.0 (changed 0.39% YoY), and the FY2023 annual result was $13171.0, changed 0.39% from the prior year.
- Other Accumulated Expenses held at $13171.0 in Q1 2023 per RGPX's latest filing, from $13120.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $13171.0 in Q1 2023 and troughed at $13120.0 in Q1 2022.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 13,171.00 |
| Mar 31, 2022 | 13,120.00 |